XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 42 filers reported holding XENON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,797,293 | -2.0% | 198,984 | +10.5% | 0.05% | -11.7% |
Q2 2023 | $6,935,505 | -35.4% | 180,143 | -40.0% | 0.06% | -41.7% |
Q1 2023 | $10,741,259 | +61.8% | 300,119 | +78.2% | 0.10% | +87.3% |
Q4 2022 | $6,640,525 | +69.9% | 168,413 | +55.5% | 0.06% | +66.7% |
Q3 2022 | $3,909,000 | +0.3% | 108,284 | -15.5% | 0.03% | -13.2% |
Q2 2022 | $3,897,000 | +24.5% | 128,109 | +25.1% | 0.04% | +35.7% |
Q1 2022 | $3,130,000 | +12.7% | 102,374 | +15.2% | 0.03% | +12.0% |
Q4 2021 | $2,777,000 | +51.3% | 88,900 | -26.0% | 0.02% | +31.6% |
Q3 2021 | $1,836,000 | +2.1% | 120,121 | +24.3% | 0.02% | 0.0% |
Q2 2021 | $1,799,000 | +20.5% | 96,600 | +15.8% | 0.02% | +5.6% |
Q1 2021 | $1,493,000 | +33.7% | 83,400 | +14.9% | 0.02% | +20.0% |
Q4 2020 | $1,117,000 | +61.2% | 72,600 | +16.0% | 0.02% | +15.4% |
Q3 2020 | $693,000 | -22.5% | 62,600 | -12.1% | 0.01% | +8.3% |
Q2 2020 | $894,000 | +508.2% | 71,200 | +447.7% | 0.01% | +33.3% |
Q1 2020 | $147,000 | -83.8% | 13,000 | -81.3% | 0.01% | -59.1% |
Q4 2019 | $910,000 | -82.1% | 69,400 | -86.1% | 0.02% | -87.5% |
Q1 2019 | $5,080,000 | +64.3% | 500,000 | +2.0% | 0.18% | +47.9% |
Q4 2018 | $3,092,000 | -58.4% | 490,058 | -12.9% | 0.12% | -63.9% |
Q3 2018 | $7,424,000 | +77.4% | 562,413 | +23.6% | 0.33% | +45.4% |
Q2 2018 | $4,186,000 | +121.8% | 455,000 | +18.2% | 0.23% | +59.9% |
Q1 2018 | $1,887,000 | +73.4% | 385,000 | 0.0% | 0.14% | +59.6% |
Q4 2017 | $1,088,000 | +34.2% | 385,000 | +40.0% | 0.09% | +20.3% |
Q3 2017 | $811,000 | +105.8% | 275,000 | +120.0% | 0.07% | +80.5% |
Q2 2017 | $394,000 | – | 125,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |